Personalized medicine: Innovative online journal leads the way

[Guest guest]

Personalized medicine: Innovative online journal leads the way

http://www.eurekalert.org/pub_releases/2008-11/bc-pmi111208.php

The recent surge of DNA sequence information resulting from

deciphering the human genetic code has acted as a catalyst for

innovative technological developments that have been vital in the

identification of genes associated with disease pathologies. This has

allowed for the development of novel genetic therapies to treat a

wide range of inherited disorders.

The new genomic era heralds earlier diagnoses, greatly improved

prevention and treatment of diseases and enhanced avoidance of side

effects from drugs.

Now, the latest information and findings that have an impact on the

understanding and management of human health and disease will be

available online to physicians around the globe with the launch of

BioMed Central's premier medical journal Genome Medicine.

Today, Genome Medicine, an online peer-reviewed open access research

journal will be launched at a special event at the 58th annual

meeting of the American Society of Human Genetics (ASHG), in

Philadelphia.

The launch issue is sponsored by Agilent, the electronic and bio-

analytical measurement company. In addition to publishing high-

quality research, Genome Medicine serves the international research

community as a forum for the discussion and critical review of

information about all areas of medicine informed by genomic research.

Genome Medicine will focus on the following areas:

Significant advances in the understanding of the genetics, genomics,

and epigenetics of disease

Computational and systems approaches, including proteomics,

metabolomics and transcriptomics, to the understanding and management

of disease

Genomic epidemiology and public health genomics

The application of genomic and post-genomic technologies to clinical

practice, with special emphasis on diagnostics and therapeutics

Personalized medicine

Ethical, social and legal issues relating to genomic medicine and

personalized medicine

Speaking of his support for the new journal, Auffray of the

Functional Genomics and Systems Biology for Health, Centre National

de la Recherche Scientifique (CNRS), France and Section Editor

said, " High-throughput experimental and computational technologies

are revolutionizing our understanding of life by enabling global

systems approaches beyond classical analytical molecular and cellular

biology. Genome Medicine is a timely initiative to foster this

transition from the highly fragmented scientific and medical

landscape to the integrative systems biology and medicine which are

needed to translate fundamental discoveries into useful healthcare

services for the benefit of individual patients worldwide. "